Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/24 21:31 | 6/26/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Followwill Dorman | CA | D | 1 | M.d | 1 | 1.37 | 0 | 1 | 333 | 1 | D | |||||||||||||||
6/20/24 18:07 | 6/20/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Wu Yue Alexander | CA | D | 1 | M.d | 7 | 1.41 | 0 | 5 | 5 | D | ||||||||||||||||
6/20/24 16:54 | 6/20/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Ma Stephen Hoi | CA | O | CFO | 2 | M.d | 15 | 0.9457 | 0 | 16 | 16 | D | |||||||||||||||
6/20/24 16:49 | 6/20/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Chun Jay | CA | D | 2 | M.d | 59 | 0.9391 | 0 | 63 | 139 | 108 | D | |||||||||||||||
6/20/24 16:43 | 6/20/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Shah Jaisim | CA | DO | See Rema | 3 | M.dm | 193 | 1.03 | 0 | 187 | 999% | 203 | D | ||||||||||||||
6/18/24 21:26 | 6/18/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | Exec Cha | 2 | M.d | 52 | 0.9365 | 0 | 56 | 9 | 662 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |